The Northwestern Medical Faculty Foundation is conducting a clinical trial on stem cell therapy for autoimmune diseases (Autoimmune Bullous Skin Disorders such as pemphigus and pemphigoid are included).
The Division of Immunotherapy is laboratory and clinic based, utilizing methods that allow the safe isolation, manipulation and preservation of population of stem cells and immune cells for therapeutic purposes.
Currently DIAD collaborates with the Divisions of Rheumatology, Nephrology, Gastroenterology and Hematology/Oncology, and the Departments of Neurology and Transplant Surgery in innovation approaches and active protocols for the treatment of severe lupus, amyloidosis, multiple sclerosis, rheumatoid arthritis and post transplant Lymphoproliferative disorders and cancers.
The Division invites inquires from physicians who would like to apply hematopoietic stem cells or immune cells toward innovative approaches to disease management and organ regeneration.
Northwestern's Clinical Areas and Conditions page
